Hydrocodone in postoperative personalized pain management: Pro-drug or drug?

Clinica Chimica Acta

Volumn 429, Issue , 2014, Pages 26-29

  Stauble, M Elaine ^a   Moore, Andrew W ^a   Langman, Loralie J ^b   Boswell, Mark V ^a   Baumgartner, Richard ^c   McGee, Suzanne ^a   Metry, Jonathan ^a   Jortani, Saeed A ^a  

^a University of Louisville School of Medicine   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

CYP2D6; Hydrocodone; Hydromorphone; Pain management

Indexed keywords

CYTOCHROME P450 2D6; DRUG METABOLITE; HYDROCODONE; HYDROMORPHONE; PRODRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; COHORT ANALYSIS; CONFUSION; CONSTIPATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIQUID CHROMATOGRAPHY; LOSS OF APPETITE; NAUSEA; NORMAL HUMAN; PERSONALIZED MEDICINE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SWEATING; TANDEM MASS SPECTROMETRY; VOMITING; WEAKNESS; XEROSTOMIA;

CYP2D6; HYDROCODONE; HYDROMORPHONE; PAIN MANAGEMENT;

ADOLESCENT; ADULT; CYTOCHROME P-450 CYP2D6; FEMALE; GENOTYPE; HUMANS; HYDROCODONE; INDIVIDUALIZED MEDICINE; MIDDLE AGED; PAIN MANAGEMENT; PAIN, POSTOPERATIVE; PRODRUGS; YOUNG ADULT;

EID: 84888864836     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.11.015     Document Type: Article

References (11)

1. Kleinrock M. The Use of Medicines in the United States: Review of 2010 2011.
2. VanderVaart S., Berger H., Sistonen J., et al. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther Drug Monit 2011, 33(4):425-432.
3. Madadi P., Ross C.J.D., Hayden M.R., et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009, 85(1):31-35.
4. Jannetto P.J., Bratanow N.C. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management. Pharmacogenomics 2009, 10(7):1157-1167.
5. Boswell M.V., Stauble M.E., Loyd G.E., et al. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone. Pain Physician 2013, 16(3):E227-E235.
6. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2011, Biomedical Publications, Seal Beach, Ca.
7. Volpe D.A., McMahon Tobin G.A., Mellon R.D., et al. Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol 2011, 59(3):385-390.
8. Ritter P.L., Gonzalez V.M., Laurent D.D., Lorig K.R. Measurement of pain using the visual numeric scale. J Rheumatol 2006, 33(3):574-580.
9. Langman L.J., Korman E., Stauble M.E., et al. Therapeutic monitoring of opioids: a sensitive LC-MS/MS method for quantitation of several opioids including hydrocodone and its metabolites. Ther Drug Monit 2013, 35(3):352-359.
10. Bernard S., Neville K.A., Nguyen A.T., Flockhart D.A. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implication. Oncologist 2006, 11:126-135.
11. Racoosin J.A., Roberson D.W., Pacanowski M.A., Nielsen D.R. New evidence about an old drug - risk with codeine after adenotonsillectomy. N Engl J Med 2013, 368(23):2155-2157.